World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
32199
World Ranking
11274
National Ranking
5787

Barry D. Kahan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Barry D. Kahan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 733 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Barry D. Kahan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Barry D. Kahan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Barry D. Kahan is affiliated with The University of Texas at Austin in the United States and has contributed primarily to the field of Medicine with a focus on several specialized subfields including Oncology, Neurology, Infectious Diseases, Public Health, Environmental and Occupational Health, and Surgery.

Their recent publications include:

  • COVID-19 Minisymposium: Toward a Strategic Roadmap (2020), Transplantation Proceedings
  • Ralph A. Reisfeld, PhD: In Memoriam (1926-2020) (2021), Cancer Research
  • The Evolution of Transplantation Proceedings: The Second of the Era Ends (2023), Transplantation Proceedings

Kahan's frequent coauthors include James P. Allison, Edward Barker, Jürgen C. Becker, Thomas F. Bumol, and David A. Cheresh.

They have published mainly in the following venues:

  • Transplantation Proceedings
  • Cancer Research

Their body of work covers several main topics, among which are:

  • COVID-19 and healthcare impacts
  • Long-Term Effects of COVID-19
  • COVID-19 Clinical Research Studies
  • Organ Donation and Transplantation
  • Organ Transplantation Techniques and Outcomes
  • Prenatal Screening and Diagnostics

Best Publications

  • Drug therapy: cyclosporine

    B. D. Kahan

  • Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

    Barry D Kahan

  • Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies.

    H Myron Kauffman;Wida S. Cherikh;Yulin Cheng;Douglas W. Hanto

  • Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.

    Barry D. Kahan;P. R. Rajagopalan;Michael Hall

  • Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation

    Anders Lindholm;Barry D Kahan

  • Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group.

    Barry D. Kahan;Bruce A. Julian;Mark D. Pescovitz;Yves Vanrenterghem

  • Results of the double-blind, randomized, multicenter, phase III clinical trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation

    Osama O. Gaber;M. Roy First;Raymond J. Tesi;Robert S. Gaston

  • Clinical pharmacokinetics of sirolimus.

    Kamran Mahalati;Barry D. Kahan

  • The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients.

    Maria G. Murgia;Samantha Jordan;Barry D. Kahan

  • Therapeutic drug monitoring of immunosuppressant drugs in clinical practice

    Barry D. Kahan;Paul Keown;Gary A. Levy;Atholl Johnston

  • Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection.

    Kahan Bd;Welsh M;Schoenberg L;Rutzky Lp

  • Individualization of Cyclosporine Therapy Using Pharmacokinetic and Pharmacodynamic Parameters

    Barry D. Kahan

  • The Impact of Comorbid and Sociodemographic Factors on Access to Renal Transplantation

    Daniel S. Gaylin;Philip J. Held;Friedrich K. Port;Lawrence G. Hunsicker

  • Rapamycin: clinical results and future opportunities.

    Barry D. Kahan;Joseph S. Camardo

  • Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.

    Joel D. Morrisett;Ghada Abdel-Fattah;Ron Hoogeveen;Eddie Mitchell

  • Salt extraction of soluble HL-A antigens.

    R. A. Reisfeld;M. A. Pellegrino;B. D. Kahan

  • Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel.

    M. Oellerich;V. W. Armstrong;B. Kahan;L. Shaw

  • Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.

    Kahan Bd;Dunn J;Fitts C;Van Buren D

  • Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration.

    James J. Zimmerman;Barry D. Kahan

  • Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study

    Marc I. Lorber;Shamkant Mulgaonkar;Khalid M.H. Butt;Elmahdi Elkhammas

Frequent Co-Authors

Ting-Chao Chou
Ting-Chao Chou Memorial Sloan Kettering Cancer Center
Ralph A. Reisfeld
Ralph A. Reisfeld Scripps Research Institute
Bruce Kaplan
Bruce Kaplan University of Colorado Anschutz Medical Campus
Jerzy W. Kupiec-Weglinski
Jerzy W. Kupiec-Weglinski University of California, Los Angeles
Soldano Ferrone
Soldano Ferrone Harvard University
Henry J. Pownall
Henry J. Pownall Houston Methodist
Christie M. Ballantyne
Christie M. Ballantyne Baylor College of Medicine
Ronald W. Busuttil
Ronald W. Busuttil University of California, Los Angeles
Hans W. Sollinger
Hans W. Sollinger University of Wisconsin–Madison
Leslie M. Shaw
Leslie M. Shaw University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their medical education or advancing in healthcare careers, there are a variety of online degree options to consider. Flexible programs can help working professionals upskill while balancing work and family commitments.

Advanced nursing programs, such as accelerated msn to dnp programs, allow registered nurses to earn a Doctor of Nursing Practice in less time. Meanwhile, those looking for convenience and flexibility can find a range of dnp online programs suitable for different schedules and learning styles.

For individuals aiming to enter the healthcare field quickly, there are online lpn programs that offer a pathway to become a Licensed Practical Nurse in a shorter timeframe. Similarly, registered nurses interested in mental health can pursue bsn to np programs online to specialize as Psychiatric Mental Health Nurse Practitioners and help address the growing demand for mental health services.

Exploring these online options can open doors to new opportunities and help shape a rewarding healthcare career in the USA.

Best Scientists Citing Barry D. Kahan

Trending Scientists

Recently Published Articles